| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
ADHSepsisOxytocinCRH Corticotropin releasing hormoneSodium (Hyponatriemia)ConivaptanShockAnaphylaxis| 1 | 2005 | Vasopressin: physiology and clinical use in patients with vasodilatory shock: a review. | 
| + | - | nl | Neth J Med 63(1):4-13 (2005) den Ouden DT |
| 2 | 2006 | The vasopressin system: physiology and clinical strategies. | 
| + | - | nl | Anesthesiology 105(3):599-612; quiz 639-40 (2006) Treschan TA |
| 3 | 2005 | Clinical review: Vasopressin and terlipressin in septic shock patients. | 
| + | - | nl | Crit Care 9(2):212-22 (2005) Delmas A |
| 4 | 2003 | Science review: Vasopressin and the cardiovascular system part 1--receptor physiology. | 
| + | - | nl | Crit Care 7(6):427-34 (2003) Holmes CL |
| 5 | 2002 | The physiology and clinical applications of vasopressin in critical illness. | 
| + | - | nl | Crit Care Resusc 4(3):181-91 (2002) Russell JC |
| 6 | 2009 | Oxytocin and vasopressin: social neuropeptides. | 
| + | - | nl | CNS Spectr 14(11):602-6 (2009) Stein DJ |
| 7 | 2008 | Gene regulation system of vasopressin and corticotropin-releasing hormone. | 
| + | - | nl | Gene Regul Syst Bio 2():71-88 (2008) Yoshida M |
| 8 | 2008 | Role of vasopressin antagonists. | 
| + | - | nl | Clin J Am Soc Nephrol 3(4):1212-8 (2008) Torres VE |
| 9 | 1965 | CELLULAR MODE OF ACTION OF ANTIDIURETIC HORMONE. | 
| + | - | nl | J Clin Pathol 18(-):533-42 (1965) |
| 10 | 2009 | Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease. | 
| + | - | nl | Liver Transpl 15(10):1325-9 (2009) |
| 11 | 2007 | Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney? | 
| + | - | nl | Crit Care 11(6):178 (2007) Bracht H |
| 12 | 2008 | Vasopressin for the management of catecholamine-resistant anaphylactic shock. | 
| + | - | nl | Singapore Med J 49(9):e225-8 (2008) |